MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated

Experimental Cell Research

Volumn 320, Issue 2, 2014, Pages 200-208

  Guo, Pin ^a   Lan, Jin ^a   Ge, Jianwei ^a   Nie, Quanmin ^a   Guo, Liemei ^a   Qiu, Yongming ^a,b   Mao, Qing ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Institute of Head Trauma   (China)

Author keywords

ATM; DNA repair; Glioblastoma multiforme; MiR 26a

Indexed keywords

LUCIFERASE; MICRORNA 26A; RADIOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; COMET ASSAY; DNA REPAIR; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION; RECOMBINATION REPAIR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR XENOGRAFT; WESTERN BLOTTING;

ATAXIA TELANGIECTASIA;

ATM; DNA REPAIR; GLIOBLASTOMA MULTIFORME; MIR-26A;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BRAIN NEOPLASMS; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE TARGETING; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; MICRORNAS; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84890856264     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.10.020     Document Type: Article

References (46)

1. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., Chin L., DePinho R.A., Cavenee W.K. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21:2683-2710.
2. Lustig R., Mikkelsen T., Lesser G., Grossman S., Ye X., Desideri S., Fisher J., Wright J. C.N.S.C. new approaches to brain tumor therapy, phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease. Neuro-Oncology 2008, 10:1004-1009.
3. Henson J.W. Treatment of glioblastoma multiforme: a new standard. Arch. Neurol. 2006, 63:337-341.
4. Reardon D.A., Wen P.Y. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. Oncologist 2006, 11:152-164.
5. Scott J.G., Suh J.H., Elson P., Barnett G.H., Vogelbaum M.A., Peereboom D.M., Stevens G.H., Elinzano H., Chao S.T. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro-Oncology 2011, 13:428-436.
6. Jiang Z., Pore N., Cerniglia G.J., Mick R., Georgescu M.M., Bernhard E.J., Hahn S.M., Gupta A.K., Maity A. Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir. Cancer Res. 2007, 67:4467-4473.
7. Karve S., Werner M.E., Sukumar R., Cummings N.D., Copp J.A., Wang E.C., Li C., Sethi M., Chen R.C., Pacold M.E., Wang A.Z. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:8230-8235.
8. Rastogi R.P., Richa A., Kumar M.B., Tyagi R.P., Sinha Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J. Nucleic Acids 2010, 2010:592980.
9. Schaue D., McBride W.H. Counteracting tumor radioresistance by targeting DNA repair. Mol. Cancer Ther. 2005, 4:1548-1550.
10. Short S.C., Martindale C., Bourne S., Brand G., Woodcock M., Johnston P. DNA repair after irradiation in glioma cells and normal human astrocytes. Neuro-Oncology 2007, 9:404-411.
11. Fattah F., Lee E.H., Weisensel N., Wang Y., Lichter N., Hendrickson E.A. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet. 2010, 6:e1000855.
12. Mao Z., Jiang Y., Liu X., Seluanov A., Gorbunova V. DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 2009, 11:683-691.
13. Golding S.E., Rosenberg E., Khalil A., McEwen A., Holmes M., Neill S., Povirk L.F., Valerie K. Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J. Biol. Chem. 2004, 279:15402-15410.
14. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 2002, 16:560-570.
15. Kastan M.B. DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol. Cancer Res.: MCR 2008, 6:517-524.
16. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6:931-942.
17. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276:42462-42467.
18. Freeman A.K., Monteiro A.N. Phosphatases in the cellular response to DNA damage. Cell Commun. Signaling: CCS 2010, 8:27.
19. Podhorecka M., Skladanowski A., Bozko P. H2AX phosphorylation: its role in DNA damage response and cancer therapy. J. Nucleic Acids 2010, 2010.
20. Bassing C.H., Chua K.F., Sekiguchi J., Suh H., Whitlow S.R., Fleming J.C., Monroe B.C., Ciccone D.N., Yan C., Vlasakova K., Livingston D.M., Ferguson D.O., Scully R., Alt F.W. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc. Nat. Acad. Sci. U.S.A. 2002, 99:8173-8178.
21. Rotman G., Shiloh Y. ATM: from gene to function. Hum. Mol. Genet. 1998, 7:1555-1563.
22. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
23. Dasika G.K., Lin S.C., Zhao S., Sung P., Tomkinson A., Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 1999, 18:7883-7899.
24. Appleby J.M., Barber J.B., Levine E., Varley J.M., Taylor A.M., Stankovic T., Heighway J., Warren C., Scott D. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br. J. Cancer 1997, 76:1546-1549.
25. Bullrich F., Rasio D., Kitada S., Starostik P., Kipps T., Keating M., Albitar M., Reed J.C., Croce C.M. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 1999, 59:24-27.
26. Vorechovsky I., Luo L., Dyer M.J., Catovsky D., Amlot P.L., Yaxley J.C., Foroni L., Hammarstrom L., Webster A.D., Yuille M.A. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat. Genet. 1997, 17:96-99.
27. Yu G., Zhu M.H., Zhu Z., Ni C.R., Zheng J.M., Li F.M. Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas 2004, 28:421-426.
28. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
29. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
30. Chaudhry M.A., Kreger B., Omaruddin R.A. Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity. Int. J. Radiat. Biol. 2010, 86:569-583.
31. G. Ke, L. Liang, J.M. Yang, X. Huang, D. Han, S. Huang, Y. Zhao, R. Zha, X. He, X. Wu, MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene, Oncogene (2012).
32. Mansour W.Y., Bogdanova N.V., Kasten-Pisula U., Rieckmann T., Kocher S., Borgmann K., Baumann M., Krause M., Petersen C., Hu H., Gatti R.A., Dikomey E., Dork T., Dahm-Daphi J. Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma. Radio. Oncol. 2013, 106:147-154.
33. Oh J.S., Kim J.J., Byun J.Y., Kim I.A. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:5-8.
34. Yan D., Ng W.L., Zhang X., Wang P., Zhang Z., Mo Y.Y., Mao H., Hao C., Olson J.J., Curran W.J., Wang Y., Targeting DNA-PKcs ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010, 5:e11397.
35. Kim H., Huang W., Jiang X., Pennicooke B., Park P.J., Johnson M.D. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc. Nat. Acad. Sci. U.S.A. 2010, 107:2183-2188.
36. Shen Y., Wang Y., Sheng K., Fei X., Guo Q., Larner J., Kong X., Qiu Y., Mi J. Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma. Cell Death Dis. 2011, 2:e241.
37. Pilch D.R., Sedelnikova O.A., Redon C., Celeste A., Nussenzweig A., Bonner W.M. Characteristics of gamma-H2AX foci at DNA double-strand breaks sites. Biochem. Cell Biol. 2003, 81:123-129.
38. Pawlik T.M., Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:928-942.
39. Zhou J., Ju W., Wang D., Wu L., Zhu X., Guo Z., He X. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One 2012, 7:e33577.
40. Zhu Y., Lu Y., Zhang Q., Liu J.J., Li T.J., Yang J.R., Zeng C., Zhuang S.M. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res. 2012, 40:4615-4625.
41. Song L., Lin C., Wu Z., Gong H., Zeng Y., Wu J., Li M., Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011, 6:e25454.
42. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004, 64:2390-2396.
43. Berkovich E., Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene 2003, 22:161-167.
44. Kim W.J., Vo Q.N., Shrivastav M., Lataxes T.A., Brown K.D. Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 2002, 21:3864-3871.
45. Huse J.T., Brennan C., Hambardzumyan D., Wee B., Pena J., Rouhanifard S.H., Sohn-Lee C., le Sage C., Agami R., Tuschl T., Holland E.C. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23:1327-1337.
46. Adams M.M., Carpenter P.B. Tying the loose ends together in DNA double strand break repair with 53BP1. Cell Div. 2006, 1:19.